Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025European Journal of Cardiovascular NursingOpen Access

Patient perceptions on lipoprotein(a) testing and treatment for secondary prevention of cardiovascular disease: results from the INTERASPIRE study in seven countries across five World Health Organization regions

View Full Paper
Ask AI
Bookmark
Share

Authors

CJCatriona JenningsEKEanna KennyDBDirk De Bacquer

Discussion

Loading...

Member takes

Overview

Survey assesses patient awareness of cardiovascular risk and Lp(a) testing acceptance across seven countries, suggesting a need for better education.

Key Points

  • Patients expressed concerns about elevated lipoprotein(a) results, yet found its testing acceptable, showing a readiness to manage cardiovascular disease risks.
  • A total of 856 patients were interviewed, including 333 with elevated lipoprotein(a) and 523 with normal levels, revealing similar knowledge about cardiovascular disease.
  • An educational approach was taken where patients received information on lipoprotein(a) prior to assessment, highlighting the role of awareness in cardiovascular health.
  • Despite the lack of licensed therapies for treating lipoprotein(a), patients showed motivation to engage in risk reduction strategies for cardiovascular disease.

Cite This Study

Jennings et al. (2025) studied this question.

synapsesocial.com/papers/68c2384fb210217d64776a4dhttps://doi.org/10.1093/eurjcn/zvaf174
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE2025 · 1 citations
  2. 2Lipoprotein(a) in clinical practice: Risk stratification and therapeutic strategies2025
  3. 3Rationale and Design of the Canadian Lipoprotein(a) Registry2026
  4. 4Lipoprotein a: what clinicians need to know2025 · 1 citations
  5. 57-039 Appropriateness of Lp(a) testing in secondary care2025